Types segmentation classifies equipment according to technical architecture and deployment context. Low‑frequency PEMF systems, typically operating below 100 Hz, dominate the clinical‑grade segment, capturing the majority of institutional spend due to their proven efficacy in bone regeneration and chronic pain mitigation. High‑frequency PEMF devices (100 Hz–10 kHz) occupy a niche but growing share, favored in neurological and cosmetic applications where deeper tissue penetration is required. Portable units, designed for point‑of‑care use, represent a fast‑expanding sub‑type, driven by sports‑medicine and home‑rehabilitation markets that prioritize mobility and lower capital outlay. Conversely, stationary clinical‑grade platforms remain the most capital‑intensive, sustaining high revenue per unit in hospital settings. Finally, home‑use devices, regulated for consumer safety, are gaining traction as insurance reimbursements expand. Each type contributes uniquely to total market size by aligning product capabilities with specific clinical protocols and user preferences, reinforcing the market taxonomy of Pulsed Electromagnetic Field Therapy Equipment.